Chikungunya Virus VLP (Virus-Like-Particle) Recombinant Protein Product Attributes
Product Type: Recombinant Protein
Recombinant Chikungunya Viral-Like-Protein based upon sequence from: Chikungunya virus (Strain: Senegal/37997). This VLP protein is combinantion of the C, E1 and E2 sequences. Virus-Like Particles (VLPs) are a new form of protein expression that consist of protein shells with outer proteins that are specific to the given virus. VLPs are immunogenic but are non-infectious, lacking the primary genetic material of the virus. Additionally, VLPs more effectively activate aspects of the immune response, which improves immune stimulation and immunological memory. VLP-based vaccines have also shown to provide effective protection and are in current use for several diseases.
Isolation Country: Senegal
NCBI Taxonomic Identifier: 371095
Taxonomy: Togaviridae -> Alphavirus -> Chikungunya virus
VIPR Database Entry: CHKV Strain-Specific Entry
VLP Protein CDS Start-End: C: 7569-8351; E1: 9996-11312; E2:8544-9812
CHIKV Protein Sequence: See above.
Host: QP10473 protein expressed in Human Cells.
Application Notes: Please contact us for application specific information for QP10473.
Purity: >90% as determined by SDS-PAGE.
Reconstitution Instructions: Reconstitute in diH2O. The buffer is already in the lyophilate.
Concentration of Chikungunya virus VLP Protein: 0.2 - 0.6 mg/ml
Endotoxin Levels: Untested
Buffer: 0.02M tris-HCl pH7.5, 0.125M sodium chloride.
Storage Conditions: Aliquot and store at -80C.
Limitations and Performance Guarantee
This is a life science research product (for Research Use Only). This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.